Interactive Financial Charts Not Available

Inari Medical (NARI) | Financial Analysis & Statements

Inari Medical Inc. | Mid-cap | Healthcare

$79.97

0.00%

Inari Medical vs Abbott Laboratories Inari Medical vs Boston Scientific Inari Medical vs Masimo Inari Medical vs Globus Medical Inari Medical vs Bio-Rad Inari Medical vs S&P 500 | Market

TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Sep 2024

Income Metrics

Revenue 153.4M

Gross Profit 133.5M 87.06%

Operating Income -6.7M -4.34%

Net Income -18.4M -11.97%

EPS (Diluted) $-0.31

Balance Sheet Metrics

Total Assets 697.2M

Total Liabilities 262.5M

Shareholders Equity 434.8M

Debt to Equity 0.60

Cash Flow Metrics

Revenue & Profitability Trend

Interactive Financial Charts Not Available

This page uses interactive financial charts and dynamic data visualization tools that require JavaScript. For detailed financial analysis:

Available Financial Data:

Income statements (annual and quarterly)
Balance sheets with asset and liability details
Cash flow statements and free cash flow analysis
Key financial ratios and performance metrics
Peer comparison and industry benchmarking

All financial data is displayed in accessible table format below. Use the table headers and structure to analyze trends and compare metrics across different periods.

Inari Medical Income Statement From 2019 to 2023

Metric	2023	2022	2021	2020	2019
Revenue i	493.6M	383.5M	277.0M	139.7M	51.1M
Cost of Goods Sold i	59.1M	44.5M	24.8M	13.1M	5.9M
Gross Profit i	434.6M	339.0M	252.2M	126.6M	45.2M
Gross Margin % i	88.0%	88.4%	91.1%	90.6%	88.4%
Operating Expenses
Research & Development i	87.5M	74.2M	51.0M	18.4M	7.2M
Selling, General & Administrative i	361.1M	292.8M	190.4M	89.7M	37.2M
Other Operating Expenses i	-	-	-	-	-
Total Operating Expenses i	448.6M	367.1M	241.4M	108.1M	44.4M
Operating Income i	-14.0M	-28.1M	10.8M	18.4M	801.0K
Operating Margin % i	-2.8%	-7.3%	3.9%	13.2%	1.6%
Non-Operating Items
Interest Income i	15.6M	1.9M	154.0K	484.0K	89.0K
Interest Expense i	196.0K	294.0K	295.0K	1.1M	920.0K
Other Non-Operating Income	2.9M	356.0K	-18.0K	-4.0M	-1.2M
Pre-tax Income i	4.2M	-26.2M	10.7M	13.8M	-1.2M
Income Tax i	5.9M	3.1M	845.0K	0	0
Effective Tax Rate % i	138.5%	0.0%	7.9%	0.0%	0.0%
Net Income i	-1.6M	-29.3M	9.8M	13.8M	-1.2M
Net Margin % i	-0.3%	-7.6%	3.6%	9.9%	-2.3%
Key Metrics
EBITDA i	15.2M	-18.8M	15.3M	19.6M	1.3M
EPS (Basic) i	$-0.03	$-0.55	$0.20	$0.43	$-0.03
EPS (Diluted) i	$-0.03	$-0.55	$0.18	$0.27	$-0.03
Basic Shares Outstanding i	56770657	52837674	49815914	32033827	38367467
Diluted Shares Outstanding i	56770657	52837674	49815914	32033827	38367467

Income Statement Trend

Inari Medical Balance Sheet From 2019 to 2023

Metric	2023	2022	2021	2020	2019
Assets
Current Assets
Cash & Equivalents i	38.6M	60.2M	92.8M	114.2M	23.6M
Short-term Investments i	76.9M	266.2M	83.3M	50.0M	0
Accounts Receivable i	70.1M	58.6M	42.4M	28.0M	11.3M
Inventory i	42.9M	32.6M	21.1M	10.6M	4.0M
Other Current Assets	6.5M	5.3M	5.7M	2.8M	464.0K
Total Current Assets i	235.6M	422.9M	245.2M	205.7M	39.4M
Non-Current Assets
Property, Plant & Equipment i	65.1M	64.3M	52.3M	4.0M	2.2M
Goodwill i	579.6M	0	-	-	-
Intangible Assets i	150.9M	-	-	-	-
Long-term Investments	-	-	-	-	-
Other Non-Current Assets	4.1M	8.9M	-	338.0K	338.0K
Total Non-Current Assets i	438.7M	81.2M	66.3M	8.4M	5.1M
Total Assets i	674.2M	504.2M	311.5M	214.1M	44.5M
Liabilities
Current Liabilities
Accounts Payable i	10.6M	7.7M	6.5M	3.0M	2.5M
Short-term Debt i	1.7M	1.3M	802.0K	-	-
Current Portion of Long-term Debt	-	-	-	-	-
Other Current Liabilities	-	-	-	-	-
Total Current Liabilities i	76.3M	56.2M	42.5M	13.8M	8.9M
Non-Current Liabilities
Long-term Debt i	30.4M	31.0M	28.4M	0	19.5M
Deferred Tax Liabilities i	36.2M	0	-	-	-
Other Non-Current Liabilities	66.4M	-	1.4M	-	-
Total Non-Current Liabilities i	133.0M	31.0M	29.8M	0	74.8M
Total Liabilities i	209.3M	87.2M	72.3M	13.8M	83.7M
Equity
Common Stock i	58.0K	54.0K	50.0K	49.0K	7.0K
Retained Earnings i	-48.5M	-46.8M	-17.6M	-27.4M	-41.2M
Treasury Stock i	-	-	-	-	-
Other Equity	-	-	-	-	-
Total Shareholders Equity i	464.9M	417.0M	239.2M	200.3M	-39.1M
Key Metrics
Total Debt i	32.0M	32.3M	29.2M	0	19.5M
Working Capital i	159.2M	366.7M	202.7M	191.8M	30.5M

Balance Sheet Composition

Inari Medical Cash Flow Statement

No cash flow data available.

Inari Medical Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -2,665.67

Forward P/E 571.21

Price to Book 10.75

Price to Sales 8.15

PEG Ratio 571.21

Profitability Ratios

Profit Margin -13.68%

Operating Margin -4.34%

Return on Equity -17.72%

Return on Assets -3.21%

Financial Health

Current Ratio 1.77

Debt to Equity 7.53

Beta 1.03

Per Share Data

EPS (TTM) $-1.35

Book Value per Share $7.44

Revenue per Share $9.90

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
nari	4.7B	-2,665.67	10.75	-17.72%	-13.68%	7.53
Abbott Laboratories	229.3B	16.53	4.53	30.93%	32.43%	26.50
Boston Scientific	153.7B	61.76	6.85	11.55%	13.55%	53.09
Masimo	8.0B	129.16	7.65	-22.37%	-21.32%	61.58
Globus Medical	8.3B	23.71	1.92	8.62%	13.58%	2.83
Bio-Rad	7.3B	22.30	0.94	4.59%	12.50%	19.73

Financial data is updated regularly. All figures are in the company's reporting currency.